Pleiotropic functions of glutathione S-transferase P

Advances in Cancer Research

Volumn 122, Issue , 2014, Pages 143-175

  Zhang, Jie ^a   Grek, Christina ^a   Ye, Zhi Wei ^a   Manevich, Yefim ^a   Tew, Kenneth D ^b   Townsend, Danyelle M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Allelic variants; Cysteine; Glutathione; Glutathione S transferase; Kinase signaling; Nitric oxide; Nitrosylation; Peroxiredoxins; Protein protein interactions; Sulfur

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; GLUTATHIONE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; GSTP1 PROTEIN, MOUSE; LIGAND; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELLULAR DISTRIBUTION; DNA POLYMORPHISM; ENZYME BINDING; ENZYME REGULATION; GENE FUNCTION; HOMEOSTASIS; HUMAN; NITROSYLATION; NONHUMAN; PHARMACOGENETICS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLEIOTROPY; PRIORITY JOURNAL; PROTEIN MODIFICATION; S GLUTATHIONYLATION; SIGNAL TRANSDUCTION; ALLELE; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; NEOPLASM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY;

ALLELES; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE S-TRANSFERASE PI; HOMEOSTASIS; HUMANS; LIGANDS; MICE; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84902978663     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420117-0.00004-9     Document Type: Chapter

References (124)

1. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., et al. Regulation of JNK signaling by GSTp. The EMBO Journal 1999, 18:1321-1334.
2. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
3. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. The Journal of Biological Chemistry 1997, 272:10004-10012.
4. Ali-Osman F., Brunner J.M., Kutluk T.M., Hess K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clinical Cancer Research 1997, 3:2253-2261.
5. Allen T.C., Granville L.A., Cagle P.T., Haque A., Zander D.S., Barrios R. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung. Human Pathology 2007, 38:220-227.
6. Allocati N., Federici L., Masulli M., Di Ilio C. Glutathione transferases in bacteria. The FEBS Journal 2009, 276:58-75.
7. Anathy V., Roberson E., Cunniff B., Nolin J.D., Hoffman S., Spiess P., et al. Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis. Molecular and Cellular Biology 2012, 32:3464-3478.
8. Asakura T., Sasagawa A., Takeuchi H., Shibata S., Marushima H., Mamori S., et al. Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis. Apoptosis 2007, 12:1269-1280.
9. Atkinson H.J., Babbitt P.C. Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry 2009, 48:11108-11116.
10. 2. The Journal of Biological Chemistry 2012, 287:81-89.
11. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:1620-1624.
12. Bernardini S., Bernassola F., Cortese C., Ballerini S., Melino G., Motti C., et al. Modulation of GST P1-1 activity by polymerization during apoptosis. Journal of Cellular Biochemistry 2000, 77:645-653.
13. Boese M., Keese M.A., Becker K., Busse R., Mulsch A. Inhibition of glutathione reductase by dinitrosyl-iron-dithiolate complex. The Journal of Biological Chemistry 1997, 272:21767-21773.
14. Bowers R.R., Manevich Y., Townsend D.M., Tew K.D. Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility. Biochemistry 2012, 51:7740-7754.
15. Burg D., Riepsaame J., Pont C., Mulder G., van de Water B. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. Biochemical Pharmacology 2006, 71:268-277.
16. Chan Q.K., Khoo U.S., Ngan H.Y., Yang C.Q., Xue W.C., Chan K.Y., et al. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma. Clinical Cancer Research 2005, 11:2981-2985.
17. Choi H.J., Kang S.W., Yang C.H., Rhee S.G., Ryu S.E. Crystal structure of a novel human peroxidase enzyme at 2.0 A resolution. Nature Structural Biology 1998, 5:400-406.
18. Corti A., Paolicchi A., Franzini M., Dominici S., Casini A.F., Pompella A. The S-thiolating activity of membrane gamma-glutamyltransferase: Formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. Antioxidants & Redox Signaling 2005, 7:911-918.
19. Cowell I.G., Dixon K.H., Pemble S.E., Ketterer B., Taylor J.B. The structure of the human glutathione S-transferase pi gene. The Biochemical Journal 1988, 255:79-83.
20. Crabtree M.J., Brixey R., Batchelor H., Hale A.B., Channon K.M. Integrated redox sensor and effector functions for tetrahydrobiopterin- and glutathionylation-dependent endothelial nitric-oxide synthase uncoupling. The Journal of Biological Chemistry 2013, 288:561-569.
21. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
22. De Luca A., Federici L., De Canio M., Stella L., Caccuri A.M. New insights into the mechanism of JNK1 inhibition by glutathione transferase p1-1. Biochemistry 2012, 51:7304-7312.
23. Desmots F., Loyer P., Rissel M., Guillouzo A., Morel F. Activation of C-Jun N-terminal kinase is required for glutathione transferase A4 induction during oxidative stress, not during cell proliferation, in mouse hepatocytes. FEBS Letters 2005, 579:5691-5696.
24. Federici L., Lo Sterzo C., Pezzola S., Di Matteo A., Scaloni F., Federici G., et al. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases. Cancer Research 2009, 69:8025-8034.
25. Federici L., Lo Sterzo C., Pezzola S., Di Matteo A., Scaloni F., Federici G., et al. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases. Cancer Research 2009, 69:8025-8034.
26. Filipovska A., Murphy M.P. Overview of protein glutathionylation. Current Protocols in Toxico 2006, Chapter 6, Unit6 10.
27. Findlay V.J., Tapiero H., Townsend D.M. Sulfiredoxin: A potential therapeutic agent?. Biomedicine & Pharmacotherapy 2005, 59:374-379.
28. Findlay V.J., Townsend D.M., Morris T.E., Fraser J.P., He L., Tew K.D. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Research 2006, 66:6800-6806.
29. Findlay V.J., Townsend D.M., Saavedra J.E., Buzard G.S., Citro M.L., Keefer L.K., et al. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Molecular Pharmacology 2004, 65:1070-1079.
30. Flohe L. The fairytale of the GSSG/GSH redox potential. Biochimica et Biophysica Acta 2012, 1830(5):3139-3142.
31. Galili N., Tamayo P., Botvinnik O.B., Mesirov J.P., Brooks M.R., Brown G., et al. Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome. Journal of Hematology & Oncology 2012, 5:20.
32. Gallogly M.M., Starke D.W., Leonberg A.K., Ospina S.M., Mieyal J.J. Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: Implications for intracellular roles. Biochemistry 2008, 47:11144-11157.
33. Gardner J.L., Gallagher E.P. Development of a peptide antibody specific to human glutathione S-transferase alpha 4-4 (hGSTA4-4) reveals preferential localization in human liver mitochondria. Archives of Biochemistry and Biophysics 2001, 390:19-27.
34. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiology, Biomarkers & Prevention 2001, 10:1239-1248.
35. Gate L., Majumdar R.S., Lunk A., Tew K.D. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. The Journal of Biological Chemistry 2004, 279:8608-8616.
36. Gate L., Majumdar R.S., Lunk A., Tew K.D. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. International Journal of Cancer 2005, 113:29-35.
37. Gildenhuys S., Wallace L.A., Burke J.P., Balchin D., Sayed Y., Dirr H.W. Class Pi glutathione transferase unfolds via a dimeric and not monomeric intermediate: Functional implications for an unstable monomer. Biochemistry 2010, 49:5074-5081.
38. Goto S., Ihara Y., Urata Y., Izumi S., Abe K., Koji T., et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi. The FASEB Journal 2001, 15:2702-2714.
39. Goto S., Ihara Y., Urata Y., Izumi S., Abe K., Koji T., et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi. The FASEB Journal 2001, 15:2702-2714.
40. Goto S., Iida T., Cho S., Oka M., Kohno S., Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radical Research 1999, 31:549-558.
41. Graminski G.F., Kubo Y., Armstrong R.N. Spectroscopic and kinetic evidence for the thiolate anion of glutathione at the active site of glutathione S-transferase. Biochemistry 1989, 28:3562-3568.
42. Graminski G.F., Zhang P.H., Sesay M.A., Ammon H.L., Armstrong R.N. Formation of the 1-(S-glutathionyl)-2,4,6-trinitrocyclohexadienate anion at the active site of glutathione S-transferase: Evidence for enzymic stabilization of sigma-complex intermediates in nucleophilic aromatic substitution reactions. Biochemistry 1989, 28:6252-6258.
43. Grek C.L., Zhang J., Manevich Y., Townsend D.M., Tew K.D. Causes and consequences of cysteine S-glutathionylation. The Journal of Biological Chemistry 2013, 288:26497-26504.
44. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. The EMBO Journal 1996, 15:2760-2770.
45. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997, 18:641-644.
46. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005, 45:51-88.
47. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology 1995, 30:445-600.
48. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., Wolf C.R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5275-5280.
49. Henderson C.J., Wolf C.R., Kitteringham N., Powell H., Otto D., Park B.K. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12741-12745.
50. Holley S.L., Fryer A.A., Haycock J.W., Grubb S.E., Strange R.C., Hoban P.R. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 2007, 28:2268-2273.
51. Hu X., Herzog C., Zimniak P., Singh S.V. Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. Cancer Research 1999, 59:2358-2362.
52. Huang J., Tan P.H., Thiyagarajan J., Bay B.H. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Modern Pathology 2003, 16:558-565.
53. Hutchens S., Manevich Y., He L., Tew K.D., Townsend D.M. Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO. Investigational New Drugs 2011, 29:719-729.
54. Isenberg J.S., Martin-Manso G., Maxhimer J.B., Roberts D.D. Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies. Nature Reviews. Cancer 2009, 9:182-194.
55. Jankova L., Robertson G., Chan C., Tan K.L., Kohonen-Corish M., Fung C.L., et al. Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: A matched historical control study. BMC Cancer 2012, 12:196.
56. Jeong W., Bae S.H., Toledano M.B., Rhee S.G. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radical Biology & Medicine 2012, 53:447-456.
57. Kavanagh J.J., Levenback C.F., Ramirez P.T., Wolf J.L., Moore C.L., Jones M.R., et al. Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. Journal of Hematology & Oncology 2010, 3:9.
58. Kou X., Chen N., Feng Z., Luo L., Yin Z. GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling. Oncology Letters 2013, 5:1053-1057.
59. Laborde E. Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death and Differentiation 2010, 17:1373-1380.
60. Lei K., Townsend D.M., Tew K.D. Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response. Oncogene 2008, 27:4877-4887.
61. Lo Bello M., Nuccetelli M., Caccuri A.M., Stella L., Parker M.W., Rossjohn J., et al. Human glutathione transferase P1-1 and nitric oxide carriers; a new role for an old enzyme. The Journal of Biological Chemistry 2001, 276:42138-42145.
62. Lo H.W., Ali-Osman F. Structure of the human allelic glutathione S-transferase-pi gene variant, hGSTP1 C, cloned from a glioblastoma multiforme cell line. Chemico-Biological Interactions 1998, 111-112:91-102.
63. Lyons R.M., Wilks S.T., Young S., Brown G.L. Oral ezatiostat HCl (Telintra(R), TLK199) and Idiopathic Chronic Neutropenia (ICN): A case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor. Journal of Hematology & Oncology 2011, 4:43.
64. Mahajan S., Atkins W.M. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cellular and Molecular Life Sciences 2005, 62:1221-1233.
65. Manevich Y., Feinstein S.I., Fisher A.B. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3780-3785.
66. Manevich Y., Fisher A.B. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radical Biology & Medicine 2005, 38:1422-1432.
67. Manevich Y., Fisher A.B. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radical Biology & Medicine 2005, 38:1422-1432.
68. Manevich Y., Hutchens S., Tew K.D., Townsend D.M. Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation. Free Radical Biology & Medicine 2012, 54C:62-70.
69. Manevich Y., Hutchens S., Tew K.D., Townsend D.M. Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation. Free Radical Biology & Medicine 2013, 54:62-70.
70. Manevich Y., Townsend D.M., Hutchens S., Tew K.D. Diazeniumdiolate mediated nitrosative stress alters nitric oxide homeostasis through intracellular calcium and S-glutathionylation of nitric oxide synthetase. PloS One 2010, 5:e14151.
71. Marino S.M., Gladyshev V.N. Structural analysis of cysteine S-nitrosylation: A modified acid-based motif and the emerging role of trans-nitrosylation. Journal of Molecular Biology 2010, 395:844-859.
72. Martinez M.C., Andriantsitohaina R. Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease. Antioxidants & Redox Signaling 2009, 11:669-702.
73. McIlwain C.C., Townsend D.M., Tew K.D. Glutathione S-transferase polymorphisms: Cancer incidence and therapy. Oncogene 2006, 25:1639-1648.
74. Mieyal J.J., Starke D.W., Gravina S.A., Dothey C., Chung J.S. Thioltransferase in human red blood cells: Purification and properties. Biochemistry 1991, 30:6088-6097.
75. Mieyal J.J., Starke D.W., Gravina S.A., Hocevar B.A. Thioltransferase in human red blood cells: Kinetics and equilibrium. Biochemistry 1991, 30:8883-8891.
76. Monaco R., Friedman F.K., Hyde M.J., Chen J.M., Manolatus S., Adler V., et al. Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics. Journal of Protein Chemistry 1999, 18:859-866.
77. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Research 1991, 51:6059-6065.
78. Pal A., Hu X., Zimniak P., Singh S.V. Catalytic efficiencies of allelic variants of human glutathione S-transferase Pi in the glutathione conjugation of alpha, beta-unsaturated aldehydes. Cancer Letters 2000, 154:39-43.
79. Park J.W., Mieyal J.J., Rhee S.G., Chock P.B. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. The Journal of Biological Chemistry 2009, 284:23364-23374.
80. Peskin A.V., Winterbourn C.C. Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Free Radical Biology & Medicine 2006, 40:45-53.
81. Petit E., Michelet X., Rauch C., Bertrand-Michel J., Terce F., Legouis R., et al. Glutathione transferases kappa 1 and kappa 2 localize in peroxisomes and mitochondria, respectively, and are involved in lipid metabolism and respiration in Caenorhabditis elegans. The FEBS Journal 2009, 276:5030-5040.
82. Pettigrew N.E., Colman R.F. Heterodimers of glutathione S-transferase can form between isoenzyme classes pi and mu. Archives of Biochemistry and Biophysics 2001, 396:225-230.
83. Ploemen J.H., Van Schanke A., Van Ommen B., Van Bladeren P.J. Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase p11. Cancer Research 1994, 54:915-919.
84. Pompella A. Redox events and cell membrane proteins. Archives of Biochemistry and Biophysics 2005, 434:1-2.
85. Ralat L.A., Manevich Y., Fisher A.B., Colman R.F. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry 2006, 45:360-372.
86. Ralat L.A., Misquitta S.A., Manevich Y., Fisher A.B., Colman R.F. Characterization of the complex of glutathione S-transferase pi and 1-cysteine peroxiredoxin. Archives of Biochemistry and Biophysics 2008, 474:109-118.
87. Raza H. Dual localization of glutathione S-transferase in the cytosol and mitochondria: Implications in oxidative stress, toxicity and disease. The FEBS Journal 2011, 278:4243-4251.
88. Raza A., Galili N., Callander N., Ochoa L., Piro L., Emanuel P., et al. Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. Journal of Hematology & Oncology 2009, 2:20.
89. Rhee S.G., Kang S.W., Chang T.S., Jeong W., Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2001, 52:35-41.
90. Ricci G., De Maria F., Antonini G., Turella P., Bullo A., Stella L., et al. 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs. The Journal of Biological Chemistry 2005, 280:26397-26405.
91. Rolland D., Raharijaona M., Barbarat A., Houlgatte R., Thieblemont C. Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin. Anticancer Research 2010, 30:3951-3957.
92. Romero L., Andrews K., Ng L., O'Rourke K., Maslen A., Kirby G. Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. The Biochemical Journal 2006, 400:135-141.
93. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. The Journal of Pharmacology and Experimental Therapeutics 2001, 298:339-345.
94. Saavedra J.E., Srinivasan A., Buzard G.S., Davies K.M., Waterhouse D.J., Inami K., et al. PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. Journal of Medicinal Chemistry 2006, 49:1157-1164.
95. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. The EMBO Journal 1998, 17:2596-2606.
96. Satyam A., Hocker M.D., Kane-Maguire K.A., Morgan A.S., Villar H.O., Lyttle M.H. Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase. Journal of Medicinal Chemistry 1996, 39:1736-1747.
97. Shelton M.D., Chock P.B., Mieyal J.J. Glutaredoxin: Role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxidants & Redox Signaling 2005, 7:348-366.
98. Singh S.P., Wishnok J.S., Keshive M., Deen W.M., Tannenbaum S.R. The chemistry of the S-nitrosoglutathione/glutathione system. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:14428-14433.
99. Soh Y., Goto S., Kitajima M., Moriyama S., Kotera K., Nakayama T., et al. Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers. Clinical Oncology (Royal College of Radiologists) 2005, 17:264-270.
100. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992, 258:1898-1902.
101. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annual Review of Pharmacology and Toxicology 1997, 37:339-359.
102. Tellez-Sanz R., Cesareo E., Nuccetelli M., Aguilera A.M., Baron C., Parker L.J., et al. Calorimetric and structural studies of the nitric oxide carrier S-nitrosoglutathione bound to human glutathione transferase p1-1. Protein Science 2006, 15:1093-1105.
103. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Research 1994, 54:4313-4320.
104. Tew K.D., Townsend D.M. Redox platforms in cancer drug discovery and development. Current Opinion in Chemical Biology 2011, 15:156-161.
105. Tew K.D., Townsend D.M. Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metabolism Reviews 2011, 43:179-193.
106. Thevenin A.F., Zony C.L., Bahnson B.J., Colman R.F. GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2. Protein Science 2011, 20:834-848.
107. Townsend D.M. S-glutathionylation: Indicator of cell stress and regulator of the unfolded protein response. Molecular Interventions 2007, 7:313-324.
108. Townsend D.M., Findlay V.J., Fazilev F., Ogle M., Fraser J., Saavedra J.E., et al. A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Molecular Pharmacology 2006, 69:501-508.
109. Townsend D.M., Manevich Y., He L., Hutchens S., Pazoles C.J., Tew K.D. Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress. The Journal of Biological Chemistry 2009, 284:436-445.
110. Townsend D.M., Manevich Y., He L., Hutchens S., Pazoles C.J., Tew K.D. Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress. The Journal of Biological Chemistry 2009, 284:436-445.
111. Townsend D., Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. American Journal of Pharmacogenomics 2003, 3:157-172.
112. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomedicine & Pharmacotherapy 2003, 57:145-155.
113. Turella P., Cerella C., Filomeni G., Bullo A., De Maria F., Ghibelli L., et al. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Research 2005, 65:3751-3761.
114. Vanin A.F. Dinitrosyl iron complexes with thiolate ligands: Physico-chemistry, biochemistry and physiology. Nitric Oxide 2009, 21:1-13.
115. Vasieva O. The many faces of glutathione transferase pi. Current Molecular Medicine 2011, 11:129-139.
116. Vergote I., Finkler N., del Campo J., Lohr A., Hunter J., Matei D., et al. Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. European Journal of Cancer 2009, 45:2324-2332.
117. Wang T., Arifoglu P., Ronai Z., Tew K.D. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. The Journal of Biological Chemistry 2001, 276:20999-21003.
118. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998, 19:275-280.
119. West M.B., Hill B.G., Xuan Y.T., Bhatnagar A. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. The FASEB Journal 2006, 20:1715-1717.
120. 2 reaction. Chemical Research in Toxicology 1994, 7:519-525.
121. Wu Y., Fan Y., Xue B., Luo L., Shen J., Zhang S., et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006, 25:5787-5800.
122. Xiong Y., Uys J.D., Tew K.D., Townsend D.M. S-glutathionylation: From molecular mechanisms to health outcomes. Antioxidants & Redox Signaling 2011, 15:233-270.
123. Xue B., Wu Y., Yin Z., Zhang H., Sun S., Yi T., et al. Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells. FEBS Letters 2005, 579:4081-4087.
124. Zimniak P., Nanduri B., Pikula S., Bandorowicz-Pikula J., Singhal S.S., Srivastava S.K., et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. European Journal of Biochemistry 1994, 224:893-899.